nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naltrexone—ABCB1—peripheral nervous system neoplasm	0.00288	0.325	CrCbGaD
Nalbuphine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00214	CcSEcCtD
Nalbuphine—Buprenorphine—ABCB1—peripheral nervous system neoplasm	0.00212	0.239	CrCbGaD
Nalbuphine—Naloxone—ABCB1—peripheral nervous system neoplasm	0.0021	0.237	CrCbGaD
Nalbuphine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00209	0.00211	CcSEcCtD
Nalbuphine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00209	CcSEcCtD
Nalbuphine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00206	0.00208	CcSEcCtD
Nalbuphine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00206	0.00208	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.00205	0.00207	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00205	0.00207	CcSEcCtD
Nalbuphine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00205	0.00206	CcSEcCtD
Nalbuphine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.00206	CcSEcCtD
Nalbuphine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00204	0.00206	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00205	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00205	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00203	0.00205	CcSEcCtD
Nalbuphine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00203	0.00205	CcSEcCtD
Nalbuphine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.002	0.00202	CcSEcCtD
Nalbuphine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.002	0.00201	CcSEcCtD
Nalbuphine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00201	CcSEcCtD
Nalbuphine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00199	0.00201	CcSEcCtD
Nalbuphine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00198	0.002	CcSEcCtD
Nalbuphine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00198	0.002	CcSEcCtD
Nalbuphine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00197	0.00199	CcSEcCtD
Nalbuphine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00197	0.00199	CcSEcCtD
Nalbuphine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00198	CcSEcCtD
Nalbuphine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00196	0.00198	CcSEcCtD
Nalbuphine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00196	0.00198	CcSEcCtD
Nalbuphine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00196	0.00198	CcSEcCtD
Nalbuphine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00196	0.00198	CcSEcCtD
Nalbuphine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00196	0.00197	CcSEcCtD
Nalbuphine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00195	0.00196	CcSEcCtD
Nalbuphine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00193	0.00194	CcSEcCtD
Nalbuphine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00194	CcSEcCtD
Nalbuphine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00192	0.00194	CcSEcCtD
Nalbuphine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00192	0.00194	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.00192	CcSEcCtD
Nalbuphine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00191	CcSEcCtD
Nalbuphine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00191	CcSEcCtD
Nalbuphine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.0019	CcSEcCtD
Nalbuphine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00185	0.00187	CcSEcCtD
Nalbuphine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00187	CcSEcCtD
Nalbuphine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00184	0.00186	CcSEcCtD
Nalbuphine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00184	0.00186	CcSEcCtD
Nalbuphine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00185	CcSEcCtD
Nalbuphine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00185	CcSEcCtD
Nalbuphine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00185	CcSEcCtD
Nalbuphine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00184	CcSEcCtD
Nalbuphine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00181	0.00183	CcSEcCtD
Nalbuphine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00181	0.00182	CcSEcCtD
Nalbuphine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.0018	0.00181	CcSEcCtD
Nalbuphine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00178	0.0018	CcSEcCtD
Nalbuphine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00178	0.0018	CcSEcCtD
Nalbuphine—Morphine—ABCB1—peripheral nervous system neoplasm	0.00177	0.2	CrCbGaD
Nalbuphine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00177	0.00179	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00176	0.00178	CcSEcCtD
Nalbuphine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00176	0.00177	CcSEcCtD
Nalbuphine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00177	CcSEcCtD
Nalbuphine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00176	0.00177	CcSEcCtD
Nalbuphine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.00177	CcSEcCtD
Nalbuphine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00175	0.00177	CcSEcCtD
Nalbuphine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00173	0.00175	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00173	0.00175	CcSEcCtD
Nalbuphine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0017	0.00172	CcSEcCtD
Nalbuphine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00169	0.00171	CcSEcCtD
Nalbuphine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00171	CcSEcCtD
Nalbuphine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00169	CcSEcCtD
Nalbuphine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.00169	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00167	0.00169	CcSEcCtD
Nalbuphine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00167	0.00168	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00166	0.00167	CcSEcCtD
Nalbuphine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00167	CcSEcCtD
Nalbuphine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00166	0.00167	CcSEcCtD
Nalbuphine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00164	0.00166	CcSEcCtD
Nalbuphine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00164	0.00166	CcSEcCtD
Nalbuphine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00163	0.00164	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00162	0.00163	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.0016	0.00162	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.0016	0.00162	CcSEcCtD
Nalbuphine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.0016	0.00162	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00161	CcSEcCtD
Nalbuphine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00159	0.00161	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00158	0.0016	CcSEcCtD
Nalbuphine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Nalbuphine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Nalbuphine—Rash—Topotecan—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Nalbuphine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Nalbuphine—Headache—Topotecan—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Nalbuphine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Nalbuphine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Nalbuphine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00158	CcSEcCtD
Nalbuphine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00158	CcSEcCtD
Nalbuphine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00158	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00156	0.00157	CcSEcCtD
Nalbuphine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00156	0.00157	CcSEcCtD
Nalbuphine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00157	CcSEcCtD
Nalbuphine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00157	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00155	0.00157	CcSEcCtD
Nalbuphine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00156	CcSEcCtD
Nalbuphine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00155	0.00156	CcSEcCtD
Nalbuphine—Rash—Melphalan—peripheral nervous system neoplasm	0.00155	0.00156	CcSEcCtD
Nalbuphine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00154	0.00156	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00155	CcSEcCtD
Nalbuphine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Nalbuphine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00151	CcSEcCtD
Nalbuphine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.0015	CcSEcCtD
Nalbuphine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.0015	CcSEcCtD
Nalbuphine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00149	0.0015	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00148	0.0015	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00148	0.00149	CcSEcCtD
Nalbuphine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00148	0.00149	CcSEcCtD
Nalbuphine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00148	0.00149	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00149	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00146	0.00147	CcSEcCtD
Nalbuphine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00146	0.00147	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00146	CcSEcCtD
Nalbuphine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00145	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00143	0.00145	CcSEcCtD
Nalbuphine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00143	0.00145	CcSEcCtD
Nalbuphine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00143	0.00145	CcSEcCtD
Nalbuphine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00144	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00142	0.00143	CcSEcCtD
Nalbuphine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.0014	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Nalbuphine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00136	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00135	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00135	CcSEcCtD
Nalbuphine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00134	0.00135	CcSEcCtD
Nalbuphine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00134	CcSEcCtD
Nalbuphine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00133	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00132	0.00133	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00131	0.00132	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00131	0.00132	CcSEcCtD
Nalbuphine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0013	0.00131	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.0013	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.00129	CcSEcCtD
Nalbuphine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00128	CcSEcCtD
Nalbuphine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00125	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00121	0.00122	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00121	0.00122	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0012	0.00121	CcSEcCtD
Nalbuphine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.0012	0.00121	CcSEcCtD
Nalbuphine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00121	CcSEcCtD
Nalbuphine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.0012	CcSEcCtD
Nalbuphine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.0012	CcSEcCtD
Nalbuphine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Nalbuphine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00116	0.00117	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00116	0.00117	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Nalbuphine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Nalbuphine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Nalbuphine—Rash—Vincristine—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Nalbuphine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Nalbuphine—Headache—Vincristine—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Nalbuphine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00113	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.0011	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Nalbuphine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00106	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Nalbuphine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00103	CcSEcCtD
Nalbuphine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Nalbuphine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.001	CcSEcCtD
Nalbuphine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00099	0.000999	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000988	0.000997	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00098	0.000989	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000971	0.00098	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00097	0.000979	CcSEcCtD
Nalbuphine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000953	0.000961	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000951	0.000959	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000934	0.000942	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000934	0.000942	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000927	0.000936	CcSEcCtD
Nalbuphine—Rash—Etoposide—peripheral nervous system neoplasm	0.000926	0.000935	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000925	0.000934	CcSEcCtD
Nalbuphine—Headache—Etoposide—peripheral nervous system neoplasm	0.00092	0.000929	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000916	0.000924	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.000922	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000907	0.000915	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000907	0.000915	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000905	0.000913	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000898	0.000906	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000887	0.000895	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00088	0.000888	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000874	0.000882	CcSEcCtD
Nalbuphine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000873	0.00088	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000871	0.000879	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.000866	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000856	0.000864	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00084	0.000848	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000839	0.000846	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000837	0.000845	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00083	0.000838	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000824	0.000831	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000821	0.000828	CcSEcCtD
Nalbuphine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00081	0.000817	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000809	0.000816	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000806	0.000813	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000804	0.000811	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000796	0.000803	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.000799	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000784	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00077	0.000776	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.000775	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000762	0.000769	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.000756	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000744	0.00075	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000739	0.000746	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.000743	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000734	0.000741	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000732	0.000739	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000725	0.000731	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000712	0.000718	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.00069	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000685	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000685	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000677	0.000683	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000673	0.000679	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000671	0.000677	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000654	0.00066	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000651	0.000657	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000651	0.000657	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000634	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.000629	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000607	0.000612	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000605	0.000611	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.000608	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.000608	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000591	0.000596	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000588	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000566	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.000552	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000549	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000544	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000528	CcSEcCtD
Nalbuphine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000519	0.000524	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000519	0.000523	CcSEcCtD
Nalbuphine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000521	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000508	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000494	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000489	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000485	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000484	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000482	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000457	CcSEcCtD
